{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:17Z","timestamp":1761514097621},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3749-8","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T07:12:49Z","timestamp":1510211569000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40\u00a0years old: a retrospective cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Peng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"issue":"2","key":"3749_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/IGC.0000000000000608","volume":"26","author":"SY Sun","year":"2016","unstructured":"Sun SY, Melamed A, Joseph NT, Gockley AA, Goldstein DP, Bernstein MR, et al. Clinical presentation of complete Hydatidiform mole and partial Hydatidiform mole at a regional Trophoblastic disease Center in the United States over the past 2 decades. Int J Gynecol Cancer. 2016;26(2):367\u201370. https:\/\/doi.org\/10.1097\/IGC.0000000000000608 .","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3749_CR2","first-page":"1","volume":"45","author":"SL Curry","year":"1975","unstructured":"Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol. 1975;45(1):1\u20138.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"3749_CR3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1470-2045(03)01245-2","volume":"4","author":"A Altieri","year":"2003","unstructured":"Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4(11):670\u20138.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3749_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/IGC.0000000000000570","volume":"26","author":"R Sun","year":"2016","unstructured":"Sun R, Zhang Y, Zheng W, Tian Q, An R, Xue Y. Clinical characteristics of gestational Trophoblastic Neoplasia: a 15-year hospital-based study. Int J Gynecol Cancer. 2016;26(1):216\u201321. https:\/\/doi.org\/10.1097\/IGC.0000000000000570 .","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3749_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/IGC.0000000000000570","volume":"26","author":"DP Goldstein","year":"2012","unstructured":"Goldstein DP, Berkowitz RS. Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am. 2012;26(1):111\u201331. https:\/\/doi.org\/10.1097\/IGC.0000000000000570 .","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"3749_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/01443615.2013.771159","volume":"33","author":"PM Savage","year":"2013","unstructured":"Savage PM, Sita-Lumsden A, Dickson S, Iyer R, Everard J, Coleman R, et al. The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome. J Obstet Gynaecol. 2013;33(4):406\u201311. https:\/\/doi.org\/10.3109\/01443615.2013.771159 .","journal-title":"J Obstet Gynaecol"},{"issue":"9","key":"3749_CR7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5858\/2004-128-1039-AHMIAP","volume":"128","author":"M Garcia","year":"2004","unstructured":"Garcia M, Romaguera RL, Gomez-Fernandez C. A hydatidiform mole in a postmenopausal woman. A case report and review of the literature. Arch Pathol Lab Med. 2004;128(9):1039\u201342.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"3749_CR8","first-page":"110","volume":"46","author":"S Limpongsanurak","year":"2001","unstructured":"Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med. 2001;46(2):110\u20136.","journal-title":"J Reprod Med."},{"issue":"2","key":"3749_CR9","first-page":"325","volume":"102","author":"EM Uberti","year":"2006","unstructured":"Uberti EM, Diestel MC, Guimar\u00e3es FE, De N\u00e1poli G, Schmid H. Single-dose actinomycin D: efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole. GynecolOncol. 2006;102(2):325\u201332.","journal-title":"GynecolOncol."},{"issue":"6","key":"3749_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","volume":"203","author":"JR Lurain","year":"2010","unstructured":"Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.073 .","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"3749_CR11","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1517\/14656566.2010.512288","volume":"11","author":"N Rodriguez","year":"2010","unstructured":"Rodriguez N, Goldstein DP, Berkowitz RS. Treating gestational trophoblastic disease. Expert Opin Pharmacother. 2010;11(18):3027\u201339. https:\/\/doi.org\/10.1517\/14656566.2010.512288 .","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"3749_CR12","first-page":"24","volume":"46","author":"S Geng","year":"2011","unstructured":"Geng S, Feng FZ, Xiang Y, Wan XR, Zhou Y. Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole. Zhonghua Fu Chan Ke Za Zhi. 2011;46(1):24\u20137.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"2","key":"3749_CR13","first-page":"47","volume":"2","author":"DK Kaye","year":"2002","unstructured":"Kaye DK. Gestational trophoblastic disease following complete hydatidiform mole in Mulago hospital, Kampala, Uganda. Afr Health Sci. 2002;2(2):47\u201351.","journal-title":"Afr Health Sci"},{"issue":"5-6","key":"3749_CR14","first-page":"254","volume":"57","author":"KM Elias","year":"2012","unstructured":"Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012;57(5-6):254\u20138.","journal-title":"J Reprod Med."},{"issue":"3","key":"3749_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0020-7292(89)90260-9","volume":"29","author":"AM Bahar","year":"1989","unstructured":"Bahar AM, El-Ashnehi MS, Senthilselvan A. Hydatidiform mole in the elderly: hysterectomy or evacuation? Int J Gynaecol Obstet. 1989;29(3):233\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5-6","key":"3749_CR16","first-page":"208","volume":"55","author":"KM Elias","year":"2010","unstructured":"Elias KM, Goldstein DP, Berkowitz RS. Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010;55(5-6):208\u201312.","journal-title":"J Reprod Med."},{"issue":"3","key":"3749_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/IGC.0000000000000903","volume":"27","author":"V Giorgione","year":"2017","unstructured":"Giorgione V, Bergamini A, Cioffi R, Pella F, Rabaiotti E, Petrone M, et al. Role of surgery in the Management of Hydatidiform Mole in elderly patients: a single-center clinical experience. Int J Gynecol Cancer. 2017;27(3):550\u20133. https:\/\/doi.org\/10.1097\/IGC.0000000000000903 .","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 3","key":"3749_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.IGC.0000503327.50238.5c","volume":"26","author":"R Lertkhachonsuk","year":"2016","unstructured":"Lertkhachonsuk R, Lertkhachonsuk AA. Outcomes of hysterectomy versus evacuation in elderly hydatidiform mole. Int J Gynecol Cancer. 2016;26(Suppl 3):539. https:\/\/doi.org\/10.1097\/01.IGC.0000503327.50238.5c .","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 1","key":"3749_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","volume":"83","author":"HY Ngan","year":"2003","unstructured":"Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S, et al. Gestational trophoblastic neoplasia, FIGO staging and classification. Int J Gynaecol Obstet. 2003;83(Suppl 1):175\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"7","key":"3749_CR20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0002-9378(80)91041-8","volume":"136","author":"CB Hammond","year":"1980","unstructured":"Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol. 1980;136(7):844\u201358.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3749_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/gyno.2002.6814","volume":"87","author":"N Pisal","year":"2002","unstructured":"Pisal N, North C, Tidy J, Hancock B. Role of hysterectomy in management of gestational trophoblastic disease. Gynecol Oncol. 2002;87(2):190\u20132.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"3749_CR22","first-page":"908","volume":"44","author":"EI Garner","year":"1999","unstructured":"Garner EI, Chang-Lee WY, Lu KH, Goldstein DP, Berkowitz RS. Trophoblastic pulmonary embolization after hysterectomy for invasive complete mole. A case report. J Reprod Med. 1999;44(10):908\u201312.","journal-title":"J Reprod Med."},{"key":"3749_CR23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1471-0528.1979.tb10694.x","volume":"86","author":"M Stone","year":"1979","unstructured":"Stone M, Bagshawe KD. An analysis of the influences of maternal age, gestational age, contraceptive method and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J ObstetGynaecol. 1979;86:782\u201392.","journal-title":"Br J ObstetGynaecol"},{"issue":"2","key":"3749_CR24","first-page":"157","volume":"22","author":"DP Goldstein","year":"1995","unstructured":"Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995;22(2):157\u201360.","journal-title":"Semin Oncol"},{"issue":"Suppl 2","key":"3749_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0020-7292(12)60026-5","volume":"119","author":"HY Ngan","year":"2012","unstructured":"Ngan HY, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, et al. Trophoblastic disease. Int J Gynaecol Obstet. 2012;119(Suppl 2):130\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"3749_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ygyno.2009.09.012","volume":"115","author":"EM Uberti","year":"2009","unstructured":"Uberti EM, FajardoMdo C, Ferreira SV, Pereira MV, Seger RC, Moreira MA, et al. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy. GynecolOncol. 2009;115(3):476\u201381. https:\/\/doi.org\/10.1016\/j.ygyno.2009.09.012 .","journal-title":"GynecolOncol"},{"key":"3749_CR27","doi-asserted-by":"publisher","unstructured":"Fu J, Fang F, Xie L, Chen H, He F, Wu T, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012;10 https:\/\/doi.org\/10.1002\/14651858 .","DOI":"10.1002\/14651858"},{"key":"3749_CR28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1097-0142(19860801)58:3<624::AID-CNCR2820580305>3.0.CO;2-6","volume":"58","author":"Y Kashimura","year":"1986","unstructured":"Kashimura Y, Kashimura M, Sugimori H, Tsukamoto N, Matsuyama T, Matsukuma K, et al. Prophylactic chemotherapy for hydatidiform mole: five to 15 years follow up. Cancer. 1986;58:624\u20139.","journal-title":"Cancer"},{"key":"3749_CR29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00006250-198605000-00017","volume":"67","author":"DS Kim","year":"1986","unstructured":"Kim DS, Moon H, Kim KT, Moon YJ, Hwang YY. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol. 1986;67:690\u20134.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"3749_CR30","first-page":"819","volume":"52","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Na YJ, Jung SG, Kim CJ, Bae SN, Lee C. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience. J Reprod Med. 2007;52(9):819\u201330.","journal-title":"J Reprod Med"},{"issue":"1","key":"3749_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ygyno.2015.05.002","volume":"138","author":"SY Sun","year":"2015","unstructured":"Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz NS, Moron AF, et al. Changing presentation of complete hydatidiform mole at the New England Trophoblastic disease center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol. 2015;138(1):46\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.002 .","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3749_CR32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/GRF.0b013e31802f17fc","volume":"50","author":"EI Garner","year":"2007","unstructured":"Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol. 2007;50(1):112\u201322.","journal-title":"Clin Obstet Gynecol"},{"issue":"2 Pt 1","key":"3749_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/AOG.0b013e3181945a4f","volume":"113","author":"LG Kerkmeijer","year":"2009","unstructured":"Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, Sweep FC, Thomas CM. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol. 2009;113(2 Pt 1):326\u201331. https:\/\/doi.org\/10.1097\/AOG.0b013e3181945a4f .","journal-title":"Obstet Gynecol"},{"issue":"177","key":"3749_CR34","first-page":"10","volume":"49","author":"K Thapa","year":"2010","unstructured":"Thapa K, Shrestha M, Sharma S, Pandey S. Trend of complete hydatidiform mole. JNMA J Nepal Med Assoc. 2010;49(177):10\u20133.","journal-title":"JNMA J Nepal Med Assoc"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T21:57:38Z","timestamp":1659823058000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3749"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3749-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"article-number":"733"}}